HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection

AIDS Research and Human Retroviruses

Volumn 15, Issue 4, 1999, Pages 317-324

  Tang, Jianming ^a   Costello, Caroline ^a   Keet, Ireneus P M ^b   Rivers, Charles ^a   Leblanc, Susan ^a   Karita, Etienne ^c   Allen, Susan ^a   Kaslow, Richard A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MUNICIPAL HEALTH SERVICE   (Netherlands)

^c National AIDS Control Program Rwanda   (Rwanda)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; FEMALE; GENOTYPE; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION;

COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE;

EID: 0033010563     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311277     Document Type: Article

References (53)

1. Coffin JM: HIV viral dynamics. AIDS 1996; 10(Suppl. 3):S75-S84.
2. Dyer WB, Geczy AF, Kent SJ, et al.: Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. AIDS 1997;11:1565-1574.
3. Ganeshan S, Dickover RE, Korber BT, Bryson YJ, and Wolinsky SM: Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J Virol 1997;71:663-677.
4. Dean M, Carrington M, Winkler M, et al.: Genetic restriction of HIV-1 infection and progression to AIDS by a common deletion allele of the chemokine receptor 5 structural gene. Science 1996;273:1856-1862.
5. Smith MW, Dean M, Carrington M, et al.: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-965.
6. Kostrikis LG, Huang Y, Moore JP, et al.: A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med 1998;4:350-353.
7. Winkler C, Modi W, Smith MW, et al.: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-393.
8. Kaslow RA, Carrington M, Apple R, et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med 1996;2:405-411.
9. Kroner BL, Goedert JJ, Carrington M, Mann DL, and Blattner WA: Concordance of haplotype sharing, CD4 decline and AIDS in hemophilic sibling pairs. AIDS 1995;9:275-280.
10. Goulder PJR, Bunce M, Krausa P, et al.: Novel, cross-restricted, conserved and immunodominant epitopes. I. Slow progressors in HIV infection. AIDS Res Hum Retroviruses 1996;12:1691-1698.
11. Goulder P, Price D, Nowak M, Rowland-Jones S, Phillips R, and McMichael A: Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev 1997;159:17-29.
12. Dupont B: Immunobiology of HLA. Springer-Verlag, New York, 1995.
13. Parham P: Functional polymorphism in class I major histocompatibility complex genes. Soc Gen Physiol Ser 1994;49:93-103.
14. Parham P, Adams EJ, and Arnett KL: The origins of HLA-A, B, C polymorphism. Immunol Rev 1995;143:141-180.
15. Zinkernagel RM-G: Immunology taught by viruses. Science 1996;272:634-636.
16. Keet IPM, Klein MR, Just JJ, and Kaslow RA: The role of host genetics in the natural history of HIV-1 infection: The needles in the haystack. AIDS 1996;10(Suppl. A):S59-S67.
17. Keet IPM, Krijnen P, Koot M, et al.: Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993;7:51-57.
18. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36:3S-15S.
19. Allen S, Van de Perre P, Serufilira A, et al.: Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis 1991;164:67-71.
20. Allen S, Lindan C, Serufilira A, et al.: Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women. JAMA 1991;266:1657-1663.
21. Lifson AR, Allen S, Wolf W, et al.: Classification of HIV infection and disease in women from Rwanda. Ann Intern Med 1995;122:262-270.
22. Lindan CP, Allen S, Serufilira A, et al.: Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 1992;116:320-328.
23. Miller SA, Dykes DD, and Polesky HF: A simple and efficient non-organic salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
24. Grimberg J, Nawoschik S, Belluscio L, McKee R, Tuck A, and Eisenberg A: A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res 1989;17:8390.
25. Bunce M, O'Neill CM, Barnardo NM, et al.: Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46: 355-367.
26. Klein MR, Keet IPM, D'Amaro J, et al.: Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis 1994;169:1244-1249.
27. Cereb N, Maye P, Lee S, Kong Y, and Yang SY: Locus-specific amplification of HLA class I genes from genomic DNA: Locus-specific sequences in the first and third introns of HLA-A and -C alleles. Tissue Antigens 1995;45:1-11.
28. Bodmer JG, Marsh SGE, Albert ED, et al.: Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997;49:297-321.
29. Marsh SGE: HLA class II region sequences. Tissue Antigens 1998;51:467-507.
30. Olerup O, Aldener A, and Fogdell A: HLA-DQB1 and HLA-DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993;41:119-134.
31. Olerup O and Zetterqist H: HLA-DR typing by polymerase chain reaction amplification with sequence-specific primers (PCR-SSP). In: Handbook of HLA Typing Techniques (Hui KM and Bidwell JL, eds.). CRC Press, Boca Raton, Florida, 1993, pp. 149-173.
32. Williams TM, Bassinger S, Moehlenkamp C, et al.: Strategy for distinguishing a new DQB1 allele (DQB1*0611) from the closely related DQB1*0602 allele via sequence specific PCR or direct DNA sequencing. Tissue Antigens 1996;48:143-147.
33. Schipper RF, D'Amaro J, Bakker JT, Bakker J, van Rood J, and Oudshoorn M: HLA gene and haplotype frequencies in Bone Marrow Donors Worldwide registries. Hum Immunol 1996;52:54-71.
34. Terasaki PI and Gjertson DW: HLA 1997. UCLA Tissue Typing Laboratory, Los Angeles, California, 1997.
35. Itescu S, Rose S, Dwyer E, and Winchester R: Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection. Hum Immunol 1995;42:81-89.
36. Rammensee HG, Friede T, and Stevanoviic S: MHC ligands and peptide motifs: First listing. Immunogenetics 1995;41:178-228.
37. Sidney J, del Guercio M-F, Southwood S, et al.: Several HLA alleles share overlapping peptide specificities. J Immunol 1995;154: 247-259.
38. Cano P, Fan B, and Stass S: A geometric study of the amino acid sequence of class I HLA molecules. Immunogenetics 1998;48:324-334.
39. Borrow P, Lweicki H, Hahn BH, Shaw GH, and Oldstone MBA: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 Infection. Virology 1994;68:6103-6110.
40. Malnati MS, Peruzzi M, Parker KC, et al.: Peptide specificity and recognition of MHC class I by natural killer cell clones. Science 1995;264:1016-1018.
41. Borrow P, Lweicki H, Wei X, et al.: Antiviral pressure exerted by HIV-1 -specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997;3:205-211.
42. Yang OO and Walker BD: CDS+ cells in human immunodeficiency virus type I pathogenesis: Cytolytic and noncytolytic inhibition of viral replication. Adv Immunol 1997;66:273-311.
43. Colonna M: Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 1997;155:127-133.
44. Goulder PJ, Phillips RE, Cobert RA, et al.: Late escape from an immunodominam cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med 1997;3:212-217:
45. Goulder PJR, Sewell AK, Lallo DG, et al.: Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J Exp Med 1997;185:1423-1433.
46. MacDonald KS, Embree J, Njenga S, et al.: Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 infection. J Infect Dis 1998;177:551-556.
47. Rosenberg ES, Billingsley JM, Caliendo AM, et al.: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278:1447-1450.
48. Just JJ: Genetic predisposition to HIV-1 infection and acquired immune deficiency syndrome. A review of the literature examining associations with HLA. Hum Immunol 1995;44:156-169.
49. Turner S, Ellexson ME, Hickman H, et al.: Sequence-based typing provides a new look at HLA-C diversity. J Immunol 1998;161: 1406-1413.
50. Potts WK and Slev PR: Pathogen-based models favoring MHC genetic diversity. Immunol Rev 1995;143:181-197.
51. Nelson GW, Goedert JJ, Kaslow RA, and Mann DL: Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection. Proc Natl Aca Sci USA 1997;94: 9802-9807.
52. Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, and Marcus-Bagley D: The immune response to hepatitis B vaccine in humans: Inheritance patterns in families. J Exp Med 1992;175:495-502.
53. Ferrari G, Humphery W, McElrath MJ, et al.: Clade B-based vaccines cliche cross-clade T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci USA 1997;94:1396-1401.